Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glioblastoma WHO Grade IV”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT07089641
What this trial is testing

ERAS-801 for the Treatment of Resectable and Progressive or Recurrent or Elderly Newly Diagnosed IDH Wildtype Grade IV Glioblastoma or Gliosarcoma With an EGFR Amplification or Mutation, ERAS801-SARG Trial

Who this might be right for
GlioblastomaGlioblastoma, IDH-WildtypeGliosarcoma+3 more
Jonsson Comprehensive Cancer Center 50
Early research (Phase 1)Active Not RecruitingNCT03389230
What this trial is testing

Memory-Enriched T Cells in Treating Patients With Recurrent or Refractory Grade III-IV Glioma

Who this might be right for
GlioblastomaMalignant GliomaRecurrent Glioma+2 more
City of Hope Medical Center 29
Testing effectiveness (Phase 2)Ended earlyNCT01870726
What this trial is testing

Safety and Efficacy of INC280 and Buparlisib (BKM120) in Patients With Recurrent Glioblastoma

Who this might be right for
c-MET Inhibitor; PI3K Inhibitor, PTEN Mutations, Homozygous Del. of PTEN or PTEN Neg. by IHC, c-Met Ampli. by FISH, INC280, BKM120, Buparlisib; Recurrent GBM
Novartis Pharmaceuticals 43
Testing effectiveness (Phase 2)Study completedNCT00813943
What this trial is testing

Cilengitide, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma and Unmethylated Gene Promoter Status

Who this might be right for
Glioblastoma
EMD Serono 265
Early research (Phase 1)Study completedNCT04757662
What this trial is testing

Tadalafil to Overcome Immunosuppression During Chemoradiotherapy for IDH-wildtype Grade III-IV Astrocytoma

Who this might be right for
Grade III AstrocytomaGrade IV AstrocytomaAstrocytoma, Grade IV+1 more
Washington University School of Medicine 18
Early research (Phase 1)Active Not RecruitingNCT04160494
What this trial is testing

D2C7-IT With Atezolizumab for Recurrent Gliomas

Who this might be right for
Malignant Glioma
Darell Bigner 18
Very early researchLooking for participantsNCT07648823
What this trial is testing

Dosimetry, Safety, and Efficacy Study of [177Lu]Lu-XT771 in Patients With Recurrent Glioblastoma

Who this might be right for
Recurrent Glioblastoma (WHO-Grade IV Glioma)Recurrent GlioblastomaGlioblastoma (GBM)+1 more
Beijing Tiantan Hospital 5
Early research (Phase 1)Study completedNCT00031083
What this trial is testing

Dose Escalation Study to Determine the Safety of IFN-Beta Gene Transfer in the Treatment of Grade III & Grade IV Gliomas

Who this might be right for
Glioblastoma MultiformeAnaplastic AstrocytomaOligoastrocytoma, Mixed+1 more
Biogen 12
Early research (Phase 1)Ended earlyNCT00272870
What this trial is testing

Treatment of Newly Diagnosed Brain Tumors With Chemotherapy and Radiation Using Cells Modified for Chemoprotection and an Experimental Drug to Decrease the Tumor Cell Resistance to Chemotherapy

Who this might be right for
Glioblastoma Multiforme (WHO Grade IV)Anaplastic Astrocytoma (WHO Grade III)
Children's Hospital Medical Center, Cincinnati 1
Early research (Phase 1)Study completedNCT00693095
What this trial is testing

Evaluation of Recovery From Drug-Induced Lymphopenia Using Cytomegalovirus-specific T-cell Adoptive Transfer

Who this might be right for
Glioblastoma
John Sampson 23
Testing effectiveness (Phase 2)Study completedNCT01866449
What this trial is testing

Prospective Phase 2 Trial of Cabazitaxel in Patients With Temozolomide Refractory Glioblastoma Multiforme

Who this might be right for
Glioblastoma Multiforme (GBM) WHO Grade IV
University of Ulm 24
Early research (Phase 1)Ended earlyNCT01558687
What this trial is testing

Cilengitide Imaging Trial in Glioblastoma

Who this might be right for
Supratentorial Newly Diagnosed Inoperable Gliobastoma
Merck KGaA, Darmstadt, Germany 1
Testing effectiveness (Phase 2)WithdrawnNCT03973879
What this trial is testing

Combination of PVSRIPO and Atezolizumab for Adults With Recurrent Malignant Glioma

Who this might be right for
Malignant Glioma
Darell Bigner
Early research (Phase 1)Ended earlyNCT04327011
What this trial is testing

A Continuation Protocol for Patients Previously Enrolled in a Study of Toca 511

Who this might be right for
Glioblastoma MultiformeAstrocytomaGliomas, Malignant
Tocagen Inc. 65
Early research (Phase 1)Study completedNCT01020292
What this trial is testing

A Trial of the Protease Inhibitor Nelfinavir and Concurrent Radiation and Temozolomide in Patients With WHO Grade IV Glioma

Who this might be right for
Glioma
Abramson Cancer Center at Penn Medicine 31
Testing effectiveness (Phase 2)Looking for participantsNCT05765812
What this trial is testing

Debio 0123 in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Debio 0123 in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed Glioblastoma

Who this might be right for
Glioblastoma IDH (Isocitrate Dehydrogenase) WildtypeAstrocytoma, Grade III
Debiopharm International SA 116
Testing effectiveness (Phase 2)Study completedNCT01854554
What this trial is testing

Glioblastoma Multiforme (GBM) Proton vs. Intensity Modulated Radiotherapy (IMRT)

Who this might be right for
Brain Cancer
M.D. Anderson Cancer Center 90
Large-scale testing (Phase 3)UnknownNCT03243461
What this trial is testing

International Cooperative Phase III Trial of the HIT-HGG Study Group (HIT-HGG-2013)

Who this might be right for
Glioblastoma WHO Grade IVDiffuse Midline Glioma Histone 3 K27M WHO Grade IVAnaplastic Astrocytoma WHO Grade III+2 more
University of Göttingen 167
Very early researchLooking for participantsNCT05423210
What this trial is testing

Atezolizumab and Pre-Surgical Brain Radiation Therapy for Glioblastoma Multiforme

Who this might be right for
Glioblastoma Multiforme
Stony Brook University 12
Not applicableNot Yet RecruitingNCT06845020
What this trial is testing

CSF Proteomic Characterization of Glioblastomas

Who this might be right for
GlioblastomaGlioblastoma WHO Grade IVGlioblastoma (GBM)+2 more
Univeridad Autonoma de Guadalajara 15
Next Page